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MicroRNA (miRNA) transfer via exosomes may
mediate cell-to-cell communication. Interestingly,
specific miRNAs are enriched in exosomes in a cell-
type-dependent fashion. However, the mechanisms
whereby miRNAs are sorted to exosomes and the
significance of miRNA transfer to acceptor cells are
unclear. We usedmacrophages and endothelial cells
(ECs) as a model of heterotypic cell communication
in order to investigate both processes. RNA profiling
of macrophages and their exosomes shows that
miRNA sorting to exosomes is modulated by cell-
activation-dependent changes of miRNA target
levels in the producer cells. Genetically perturbing
the expression of individual miRNAs or their tar-
geted transcripts promotes bidirectional miRNA re-
location from the cell cytoplasm/P bodies (sites of
miRNA activity) to multivesicular bodies (sites of
exosome biogenesis) and controls miRNA sorting
to exosomes. Furthermore, the use ofDicer-deficient
cells and reporter lentiviral vectors (LVs) for miRNA
activity shows that exosomalmiRNAs are transferred
from macrophages to ECs to detectably repress tar-
geted sequences.INTRODUCTION
MicroRNAs (miRNAs/miRs) are a class of small noncoding RNAs
that regulate gene expression at the posttranscriptional level
(Yates et al., 2013). Precursor miRNAs are exported from the
cell nucleus to the cytoplasm, where they are processed into
mature miRNAs by the enzyme DICER. Upon loading into the
RNA-induced silencing complex (RISC), miRNAs bind the 30
UTR of target transcripts to fine-tune their expression via degra-
dation and/or translational repression (Bartel, 2009). Several
hundreds of mature miRNAs have been identified in metazoans,1432 Cell Reports 8, 1432–1446, September 11, 2014 ª2014 The Aumany of which are predicted to modulate the expression of
multiple gene transcripts (Lewis et al., 2005). miRNAs are also
detected in extracellular compartments, such as body fluids,
either in complex with proteins of the argonaute (AGO) family
or loaded into exosomes (Turchinovich et al., 2012). Exosomes
are microvesicles produced by multiple cell types, which origi-
nate from the fusion of late endosomes/multivesicular bodies
(MVBs) with the cell plasma membrane. Upon their release in
the extracellular environment, exosomes can fuse with live cells,
either paracrinally or endocrinally, and transfer their cargo of
proteins, lipids, and RNAs to the acceptor cells (Simons and Ra-
poso, 2009).
RNA sequencing (RNA-seq) has shown that miRNAs are abun-
dant in exosomes. Notably, the miRNA repertoire of exosomes
may differ from that of the producer cell (Gibbings et al., 2009;
Guduric-Fuchs et al., 2012; Nolte-’t Hoen et al., 2012; Simons
and Raposo, 2009; Skog et al., 2008; Valadi et al., 2007). This
finding suggests that the sorting of specific miRNA species
to exosomes may be actively regulated, although the underlying
mechanisms remain largely unknown. Both the process of MVB/
exosome biogenesis and miRNA-sequence-specific determi-
nants may modulate miRNA sorting to exosomes. Members of
the endosomal sorting complex required for transport (ESCRT)
play crucial functions in MVB biogenesis and exocytosis. How-
ever, knockdown of ESCRT proteins does not affect miRNA sort-
ing to exosomes (Kosaka et al., 2010). A recent study identified a
specific 4 nt sequence (GGAG) that is overrepresented in miR-
NAs that are enriched in T cell-derived exosomes. The GGAG
motif is bound by sumoylated hnRNPA2B1 (a heterogeneous
nuclear riboprotein), which directs miRNA trafficking to MVBs
and their secretion via exosomes (Villarroya-Beltri et al., 2013).
Thus, specific motifs present in certain miRNAs may guide their
sorting to exosomes through the interaction with specific chap-
eron proteins.
Multiple cell types, such as immune cells, endothelial cells
(ECs), and cancer cells, can internalize exosomes secreted by
other cells. Several studies have proposed that the transfer of
exosomal miRNAs may modulate the biological functions of
the acceptor cells (Hergenreider et al., 2012; Mittelbrunn et al.,
2011; Montecalvo et al., 2012; Ramachandran and Palanisamy,thors
2012; Valadi et al., 2007). Nevertheless, distinguishing exoge-
nous miRNA transfer/activity from the endogenous activation
of miRNA transcription/activity consequent to exosome-cell
physical interactions may prove challenging; therefore, definitive
evidence for the robustness of transfer of miRNA activity from
exosomes to acceptor cells remains scant. In this study, we em-
ployed macrophages and ECs as a model system to investigate
the molecular determinants of miRNA sorting to exosomes and
transfer to acceptor cells. Our findings indicate that miRNA
sorting to exosomes is regulated, at least in part, by cell-activa-
tion-dependent changes of targeted transcript levels in the cell
cytoplasm. Furthermore, by employing sensitive reporter lentivi-
ral vectors (LVs), we show that transfer of miRNA activity from
macrophage-derived exosomes has the potential to detectably
modulate the gene expression and biology of acceptor ECs.
RESULTS
Cell-Activation-Dependent miRNA Enrichment
in Exosomes
We isolated microvesicles secreted by colony-stimulating fac-
tor 1 (CSF-1)-induced bone marrow-derived macrophages
(BMDMs) that were either untreated (UT) or stimulated with inter-
leukin-4 (IL-4). As expected, IL-4 increased the expression of the
‘‘alternative macrophage activation’’ genes Arg1, CD163, and
Mrc1 in BMDMs (Figure S1A). BMDM-derived microvesicles
were highly enriched in particles that had features of exosomes,
as shown by physical size analysis by dynamic light scattering
(Figure S1B) and protein content by western blotting analysis
(Figure S1C). From here on, we refer to macrophage-derived
exosomes as ‘‘exo-macs.’’
We profiled the miRNA transcriptome of BMDMs and their
exo-macs, either UT (n = 3) or IL-4 treated (IL-4; n = 3), by low-
density quantitative PCR (qPCR) arrays. A total of 178 (29%) of
the 618 miRNAs present in the arrays were detected in at least
two out of three biological replicates of both BMDMs and exo-
macs (Table S1). After quantile normalization of the data, 31
miRNAs (5%) were differentially expressed in IL-4-treated versus
UT BMDMs (Figure 1A; Table S2A), including miR-138-5p, miR-
9-3p (both upregulated; fold-change [FC] = 59 and 16, respec-
tively), miR-146a-5p, and miR-223-3p (both downregulated;
FC = 0.10 and 0.27, respectively). We also identified 40 miRNAs
(6%) that were relatively increased or decreased in the exo-macs
by IL-4 (Figure 1B; Table S2B). These data indicate that IL-4
modulates the expression and/or enrichment of a subset of
miRNAs in BMDMs and their exo-macs.
The global miRNA profile greatly differed in BMDMs and exo-
macs, regardless of IL-4 stimulation, as shown by the unsuper-
vised hierarchical clustering of the data (Figure 1C). Of the 178
miRNAs detected in all samples, 90 (51%) and 101 (57%) were
relatively increased/decreased in the exo-macs compared to
UTand IL-4-treatedBMDMs, respectively (Figures1Dand1E;Ta-
bles S2CandS2D). Among themiRNAs enriched in the exo-macs
weremiR-150-5p,miR-146a-5p,miR-320-3p,miR-467b-3p, and
miR-467f; of these, miR-150-5p, miR-146a-5p, and miR-320-3p
were previously found to be enriched in exosomes derived from
distinct cell types (Guduric-Fuchs et al., 2012). Furthermore, 39
miRNAs were relatively increased or decreased in the exo-macsCell ReversusBMDMs inan IL-4-dependentmanner (e.g.,moreenriched
in exo-macs by IL-4; Figures 1F and 1G; Table S2E).
Although our experimental conditions and analyses cannot
measure absolute miRNA abundance in exo-macs and producer
BMDMs, they indicate that (1) selected miRNAs are differentially
represented in exo-macs and BMDMs (relative to the global
miRNA repertoire), and (2) miRNA enrichment in exo-macs is
not only miRNA-specific but also dependent on the cell activa-
tion state. From here on, we refer to miRNAs contained in exo-
macs as ‘‘exo-miRNAs.’’
Artificially Perturbing miRNA or Targeted Transcript
LevelsModulatesmiRNASorting toMVBs andExosomes
Little is known of the molecular regulation of miRNA sorting to
exosomes. In order to explore potential mechanisms, we first
generated miRNA-deficient BMDMs by transducing bone
marrow-derived cells from Dicerfl/fl mice with a Cre-expressing
LV (Figure S2A). We then analyzed a panel of miRNAs in either
Dicerfl/fl or Dicer/ BMDMs, and their secreted exo-macs, at
day 12 posttransduction, a time point when Dicer had been effi-
ciently (albeit nonexhaustively) deleted in the LV-transduced
BMDMs (Figure S2B). Intriguingly, miRNA depletion was sub-
stantially more prominent in the exo-macs than in the producer,
Dicer/ cells, regardless of IL-4 stimulation (Figures 2A and 2B).
This was true for each miRNA analyzed and was independent of
the expression level of the miRNA in Dicer-proficient BMDMs.
Thus, upon acute Dicer deletion in BMDMs, a moderate miRNA
decrease in the cells is associated with amore prominent miRNA
depletion in the exo-macs.
To further investigate this phenomenon, we asked whether
changes in the abundance of a given miRNA and/or its targets
(including artificial and natural targets) could alter miRNA sorting
to the exosomes. In order to standardize experimental condi-
tions, we generated a macrophage cell line by immortalizing
Dicerfl/fl BMDMs with an LV expressing the SV40 large T antigen
(Figure S2A). A clonal population of immortalized BMDMs
(iBMMs) expressed all analyzed macrophage-specific markers,
could be polarized in response to cytokine (IL-4 or LPS plus
IFN-g) stimulation, and was dependent on CSF-1 for survival
and growth (Figures S2C–S2F). Furthermore, iBMMs produced
bona fide exo-macs, as shown by physical size analysis by dy-
namic light scattering (Figure S2G), morphology by transmission
electron microscopy (Figure S2H), and protein content by west-
ern blotting analysis (Figure S2I). Thus, iBMMs represent a suit-
able surrogate cell line for primary BMDMs.
UT iBMMs express low levels of miR-511-3p, a macrophage-
specific miRNA that is induced by IL-4 (Squadrito et al., 2012).
We then transduced iBMMs with increasing doses of an LV over-
expressingmiR-511-3p (Squadrito et al., 2012 and Figure 2C) and
analyzed miR-511-3p levels in iBMMs and their exo-macs. Upon
increasing overexpression,miR-511-3p levels surged to a greater
extent in theexo-macs than in the iBMMs (Figure2D). Thus, partial
miRNA depletion strongly limits (see Figures 2A and 2B) while
miRNA overexpression strongly enhances miRNA sorting to exo-
somes. In a series of parallel experiments,we analyzed the effects
of artificially increasing the cellular levels ofmiR-511-3p target se-
quences. To this aim, we transduced the iBMMs with increasing
doses of an LV expressing eight copies of artificial sequencesports 8, 1432–1446, September 11, 2014 ª2014 The Authors 1433
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with perfect complementarity to miR-511-3p (Figure 2C). Robust
overexpression of artificial miRNA target sequences detectably
decreased endogenous miR-511-3p levels in the iBMMs (Fig-
ure 2E), likely through a ‘‘miRNA sponge effect’’ (Brown and Nal-
dini, 2009; Denzler et al., 2014; Gentner et al., 2009; Mullokandov
et al., 2012). However, miR-511-3p levels decreased in the exo-
macs to a greater extent than in the iBMMs. Finally, iBMMs engi-
neered to overexpress increasing levels of both miR-511-3p and
its target sequences by sequential LV transduction showed that
miRNA transfer to exo-macs is controlled by the relative levels
of the miRNA and its target sequences in the cell (Figure 2F).
Indeed, quantification of miR-511-3p, either after normalization
to Let-7a-5p or by absolute copy-number analysis, indicated
that maximal overexpression of miR-511-3p target sequences
(‘‘artificial targets 2’’ in Figure 2F) reversed the exosomal enrich-
ment of miR-511-3p that was induced by its overexpression.
While artificial (perfectly complementary) sequences may pro-
mote miRNA-dependent cleavage of the target, natural (partially
complementary) sequences may cause mRNA destabilization
and translation inhibition (Ameres et al., 2007). We then em-
ployed natural target sequences for miR-511-3p. We previously
validated Rock2 as a natural target of miR-511-3p (Squadrito
et al., 2012). We then transduced iBMMs with increasing doses
of an LV expressing a fragment of the Rock2 30 UTR that encom-
passes target sites for miR-511-3p (Rock2 30UTR LV; Figure 2C).
As a control LV, we used Rock2 30 UTR sequences with mutated
miR-511-3p binding sites (Squadrito et al., 2012). Whereas nat-
ural target sequences did not ‘‘sponge’’ endogenous miR-511-
3p detectably in the cells (contrary to artificial sequences; see
Figures 2D–2F), they efficiently decreased miR-511-3p levels in
the exo-macs (Figure 2G). Taken together, these findings indi-
cate that artificially increasing the abundance of miRNA target
sequences limits miRNA levels in the exosomes more markedly
than in the producer cells.
MVBs are complex organelles that function as sites of exo-
some biogenesis (Simons and Raposo, 2009). Based on our
finding that artificially increasing the expression of a given
miRNA disproportionally increases its levels in the exosomes,
we hypothesized that artificially overexpressed miRNAs would
also enrich inMVBs.We then performed subcellular fractionation
of iBMMs (Gibbings et al., 2009; Stalder et al., 2013) and ob-
tained nine distinct subcellular fractions that were analyzed by
western blotting (Figures 3A and S3A). MVBs were enriched in
fraction 3 and, to a lesser extent, fractions 2 and 4, as shown
by expression of the tetraspanin CD81 (Figure 3A). Fractions 4
to 9 were enriched in endoplasmic reticulum (ER), as shown byFigure 1. miRNA Analysis in BMDMs and Their Exo-Macs
(A and B) Selected miRNAs (indicated as miRs) increased or decreased in BMDM
show fold-change (FC) in IL-4-treated versus UT BMDMs/exo-macs (FC = 2DCt,
analysis by moderated t-statistics adjusted for false discovery rate (FDR); *p < 0.0
array and measured separately (FC = 2DDCt, with Ct values normalized to U6; m
(C) Mean-centered heatmap showing unsupervised hierarchical clustering of miR
their exo-macs (exo-mac.1-3 and exo-mac.1-3_IL-4).
(D and E) Selected miRNAs increased or decreased in exo-macs versus BMDMs
(F andG) Differential miRNA increase/decrease in exo-macs versus BMDMsby IL-
IL-4. Data are shown as FC between FCIL-4 and FCUT (mean ± SEM, n = 3). Stati
(FCUT, y axis) or IL-4-treated (FCIL-4, x axis) BMDMs. miRNAs significantly incre
A and B).
Cell Reexpression of calnexin (CNX), whereas fraction 1 and, to a lesser
extent, fraction 2 were enriched in P bodies markers, such as
AGO2, GW182, and DCP1A, indicative of sites of miRNA activity
(Liu et al., 2005). We then transduced iBMMs with a high dose of
an LV overexpressing miR-511-3p, or a mutated form (miR-511-
3p-mut; Figure S3B; Squadrito et al., 2012), and performed sub-
cellular fractionation. In iBMMs expressing miR-511-3p-mut,
endogenous miR-511-3p was detectable, albeit at varying
levels, in each fraction (Figure 3B). Overexpressing miR-511-
3p increased its levels in all subcellular fractions (data not
shown); however, it did so more prominently in the MVB-en-
riched fraction 3 compared to the other fractions. Conversely,
overexpressing artificial (perfectly complementary) or bulge
(partially complementary) target sequences for miR-511-3p in
the iBMMs (Figure S3B) significantly increased miR-511-3p
levels in the P bodies-enriched fraction 1 (Figures 3C and 3D).
Together, these data indicate that artificially increasing the
cellular levels of a miRNA or its target sequences favors miRNA
enrichment in MVBs (miRNA secretory pathway) and P bodies
(miRNA activity pathway), respectively. Thus, fluctuations of
natural target levels may have the potential to relocate miRNAs
from one cellular compartment to another and tilt the balance be-
tween endogenous miRNA activity and secretion through the
MVB/exosome pathway.
Cell Activation Modulates miRNA:Target Interactions
and Controls miRNA Sorting to Exosomes
Based on the aforementioned findings, we hypothesized that the
transcriptional changes that occur in response to cell activation
may control miRNA sorting to exosomes by either increasing or
decreasing the pool of intracellular miRNA target sequences. To
test this hypothesis, we performed RNA-seq of UT (n = 4) and IL-
4-treated (n = 4) primary BMDMs. We unequivocally identified
36,000 transcripts (including protein-coding and noncoding
RNAs), of which 21% were differentially expressed (by edgeR;
adjusted p value < 0.05) in the BMDMs upon IL-4 treatment (Fig-
ure 4A; Table S3). As expected, IL-4 increased the expression of
genes known to be upregulated in alternatively activated macro-
phages (Martinez et al., 2009), such as Arg1, Retnla, Chi3l3
(Ym1), Ccl22, and Mrc1 (Figure S4A).
We then implemented a computational model to investigate
whether IL-4-induced changes in exo-miRNA levels (see Figures
1 and S1) were dependent on quantitative changes in miRNA
target levels in the BMDMs. We first selected miRNAs with at
least two out of three determinations in the qPCR array data
sets of both BMDMs and exo-macs (178 miRNAs; see Figure 1).s (A) and exo-macs (B) by IL-4, analyzed by low-density TaqMan arrays. Data
with Ct values normalized by quantile method; mean ± SEM, n = 3). Statistical
5; **p < 0.01; ***p < 0.001, xp = 0.0502. # indicates a miRNA not present in the
ean ± SEM, n = 3; p = 0.0134; statistical analysis by unpaired Student’s t test).
NA levels in UT (BMDM.1-3) and IL-4-treated (BMDM.1-3_IL-4) BMDMs and
, either UT (D) or IL-4 treated (E). Analysis as in (A) and (B).
4. (F) SelectedmiRNAs increased or decreased in exo-macs versus BMDMsby
stical analysis as in (A) and (B). (G) FC of miRNA levels in exo-macs versus UT
ased/decreased are shown in red (adjusted p < 0.05; statistical analysis as in
ports 8, 1432–1446, September 11, 2014 ª2014 The Authors 1435
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We then used the UCSC Genome Browser database (http://
genome.ucsc.edu) to select transcripts that contain a 30 UTR
sequence. We identified miRNA target sites (seed:RNA interac-
tions) in each transcript’s 30 UTR and rationally assigned aweight
to each of the three main typologies of the seed:RNA interaction
(8-mer > 7-mer > 6-mer) to obtain a ‘‘weighted interaction score’’
for each transcript (WISt; Supplemental Experimental Proce-
dures). Although 50 UTRs and open reading frames (ORFs) of
mammalian genes contain predicted miRNA target sites, their
contribution to miRNA-mediated gene repression is deemed
marginal (Bartel, 2009; Grimson et al., 2007); therefore, only 30
UTRsequenceswere analyzed.We then used fragments per kilo-
base per million of reads (FPKM) data to determine, for each
miRNA, the weighted interaction score at the transcriptome-
wide level (referred to as WIS) in either UT or IL-4-treated
BMDMs. Lastly, we calculated the ratio between WIS values in
IL-4-treated and UT BMDMs (WIS-ratio). Based on this model,
miRNAs whose predicted targets are decreased in BMDMs by
IL-4 have a WIS-ratio < 1, or ln(WIS-ratio) < 0, whereas miRNAs
whose predicted targets are increased in BMDMs by IL-4 have
a WIS-ratio > 1, or ln(WIS-ratio) > 0.
Interestingly, we found a weak but statistically significant anti-
correlation (p < 0.008) between the WIS-ratio values of miRNAs
and their enrichment in the exo-macs (Figures 4B and 4C). The
observed anticorrelation was verified also when we employed
D-WIS values (p < 0.01), which measure the absolute increase
or decrease (D) of the WIS of each miRNA in the transcriptome
of IL-4-treated versus UT BMDMs (Figure S4B). Thus, miRNAs
whose predicted targets are globally decreased in BMDMs by
IL-4 appear to be preferentially enriched in exosomes, and vice
versa. It should be noted that we did not observe a statistically
significant correlation between WIS-ratio values and differential
miRNA expression in IL-4-treated versus UT BMDMs (Fig-
ure S4C), suggesting that cell-activation-dependent changes
ofmiRNA target abundance do not globally impact on the cellular
miRNA levels.
We then studied the contribution of individual transcripts to the
WIS of each of the 178 selected miRNAs. We first ranked the
cellular transcripts based on the magnitude of their contribution
to the WIS in IL-4-treated versus UT BMDMs (i.e., by using
D-WISt values). We then monitored in silico, for each miRNA the
behavior of the WIS in response to the contribution of individual
transcripts.We found that, on average, the transcriptwith highest
D-WISt could contribute to increase or decrease theWIS by5%Figure 2. Changes of miRNA Levels or Their Target Sequences Contro
(A and B) TaqMan analysis of selected miRNAs (indicated as miRs) in Dicer+/+ an
either UT (A) or IL-4 treated (B). Data show FC (FC = 2DDCt, with Ct values normali
bars, upper panels) or their exo-macs (black bars, bottom panels). In the top pane
by two-way ANOVA, with Sidak’s multiple comparisons test.
(C) Schematics of proviral LVs.
(D and E) Top graphs showmiR-511-3p levels (D, normalized to Let-7a-5p; E, diffe
macs. iBMMs were transduced with increasing doses (D, 1–4; E, 1–3) of LVs eit
0 indicates untransduced iBMMs. FACS dot plots on the bottom show iBMMs tra
(F) miR-511-3p levels in iBMMs and exo-macs. iBMMs were cotransduced wi
sequences, as indicated. miR-511-3p levels were either normalized to Let-7a-5p
ANCOVA.
(G) miR-511-3p levels normalized to Let-7a-5p in iBMMs and exo-macs. iBMMs w
the Rock2 30 UTR. Data show FC versus exo-macs or iBMMs transduced with a
Cell Re(0.6%–32%; Figure 4D). For example, the matrix metalloprotei-
nase-12 (Mmp12) transcript, which is targeted by miR-218-5p
and upregulated 26-fold in IL-4-treated BMDMs (Table S3),
increased the WIS of miR-218-5p by 8% (Figure 4E). Prosapo-
sin (Psap; upregulated 2-fold by IL-4; Table S3) further
increased the WIS of miR-218 by 6%, whereas lysozyme-2
(Lyz2; downregulated 2-fold by IL-4; Table S3; Figure S4D)
decreased it by4.5%.Of note, theMmp12,Psap, andLyz2 tran-
scripts are all highly expressed in BMDMs (Figure 4F). When all
cellular transcripts were computed, IL-4 increased the WIS of
miR-218-5p by 13.6%. Consistent with the in silico prediction,
miR-218-5p levels were relatively lower in the exo-macs derived
from IL-4-treated BMDMs than UT BMDMs (see Figure 1E and
Table S2E). Among the miRNAs whose WIS decreased after
IL-4 was miR-99b-5p (Figure 4E), a miRNA upregulated in the
exo-macs in an IL-4-dependent fashion (see Figure 1F). Of
note, IL-4 stimulation of BMDMs more frequently increased
than decreased the WIS of the investigated miRNAs (Figure 4D).
To validate the aforementioned in silico data, we analyzed the
effects of biological Lyz2 gene knockout on miR-218-5p sorting
to exo-macs. To this aim, we used BMDMs obtained from ho-
mozygous Lyz2.Cre mice (Clausen et al., 1999), which lack
both functional copies of Lyz2 (Figure 4G). As predicted by our
model, miR-218-5p, but not miR-16-5p, which does not have
binding sites in the 30 UTR of the Lyz2 transcript, was enriched
in the exo-macs of Lyz2.Cre BMDMs compared to wild-type
BMDMs (Figures 4H and S4D). Of note, miR-218-5p levels
were similar in wild-type and Lyz2 null BMDMs, suggesting
that the Lyz2 transcript, while containing 13% of all miR-
218-5p binding sites in the coding and noncoding transcrip-
tome, would not modulate the cellular levels of miR-218-5p
through a sponge effect.
miRNAs belonging to the same family share the same seed
sequence, which controls target recognition (Lai, 2002). Based
on our model, miRNA family members should display a similar
sorting pattern. To study the behavior of miRNAs that either
share or not the same seed sequence, we performed an
in silico analysis. We calculated the difference between pairs
of fold-change values (D-FC) measuring miRNA increase/
decrease in exo-macs versus BMDMs by IL-4 (see Figure 1F
and Table S2E) for all possible miRNA pairs. We found that
miRNA pairs sharing the same seed sequence displayed signif-
icantly smaller D-FC values than randomly selected miRNA pairs
(Figure 4I). Of note, miRNA pairs sharing 3-mer or 4-merl miRNA Sorting to Exo-Macs
d Dicerfl/fl BMDMs transduced with a Cre-expressing LV, and their exo-macs,
zed to U6; mean ± SEM, n = 2–3) versus LV-transducedDicer+/+ BMDMs (black
ls, miRNA DCt values (versus U6) are indicated for BMDMs. Statistical analysis
rence between normalized levels in exo-macs versus cells) in iBMMs and exo-
her overexpressing miR-511-3p (D) or its artificial target sequences (E); dose
nsduced as indicated. Statistical analysis by analysis of covariance (ANCOVA).
th increasing doses of LVs overexpressing miR-511-3p or its artificial target
or shown as absolute miRNA copies per pg of total RNA. Statistical analysis by
ere transduced with increasing doses (1–3) of an LV expressing a fragment of
mutated Rock2 30 UTR (mean ± SEM, n = 3). Statistical analysis by ANCOVA.
ports 8, 1432–1446, September 11, 2014 ª2014 The Authors 1437
Figure 3. Relocation of miRNAs to Distinct
Subcellular Compartments
(A) Western blotting analysis of subcellular frac-
tions obtained from iBMMs. Three of six inde-
pendent experiments are shown.
(B–D) miR-511-3p levels in subcellular fractions
obtained from iBMMs transduced with LVs over-
expressing miR-511-3p (B, versus miR-511-3p-
mut), its artificial (perfectly complementary) target
sequences (C, versus scrambled target), or its
bulge (nonperfectly complementary) target se-
quences (D, versus scrambled target). For each
fraction, miRNA levels are shown as DCt values
(difference between the Ct in the fraction of inter-
est and the mean Ct calculated on all fractions).
One representative experiment of three performed
is shown for (B) and (C); statistical analysis of the
data was performed on the three biological repli-
cates (B and C) by two-way ANOVA, with Sidak’s
multiple comparison test (#p < 0.01).sequences located outside the seed sequence behaved similarly
to random miRNA pairs.
Taken together, our results suggest that the cellular levels of
natural miRNA targets, which dynamically change in response
to cell activation, maymodulate miRNA enrichment in exosomes
without detectably affecting the cellular miRNA levels.
Macrophage-Derived Exosomes Transfer miRNA
Activity to Acceptor Endothelial Cells
Macrophages modulate EC biology and stimulate angiogenesis
by secreting growth factors and matrix-remodeling enzymes1438 Cell Reports 8, 1432–1446, September 11, 2014 ª2014 The Authors(Baer et al., 2013). Furthermore, miRNA
transfer via exosomes may mediate
macrophage-to-EC communication and,
therefore, potentially influence macro-
phage-regulated angiogenesis. In order
to visualize and measure exo-mac trans-
fer to ECs, we generated fluorescently
labeled exo-macs by transducing iBMMs
with an LV expressing a CD9 cDNA fused
with either mCherry (SFFV.CD9.mCherry)
or enhanced GFP (SFFV.CD9.eGFP)
(Figure S5A). Fluorescence spectroscopy
showed readily measurable, proteinase-
resistant mCherry fluorescence in the
exo-macs (Figures S5B–S5D). In order
to study exo-mac transfer, we estab-
lished immortalized, endothelial-like cells
(iELCs) from the heart of Dicerfl/fl mice
and treated them with increasing doses
of mCherry+ exo-macs. Flow cytometry
of iELCs showed dose-dependent
mCherry fluorescence (Figure S5E).
iELCs rapidly internalized exo-macs (Fig-
ure S5F), which became evident in the
cell cytoplasm as punctate mCherry
staining (Figure S5G). A similar intracel-
lular pattern of mCherry was observedwhen iELCs were cocultured with CD9.mCherry+ iBMMs (Fig-
ure S5H). LAMP1 staining of iELCs, or their transduction with a
LAMP1-eGFP fusion protein (Lysotracker), indicated that a sig-
nificant proportion of themCherry signal colocalized with late en-
dosomes/lysosomes (Figures S5I and S5J), as previously shown
in other studies (Morelli et al., 2004). Whereas these data show a
rapid and dose-dependent exo-mac uptake by ECs, they also
indicate that a sizable proportion of the uptaken exo-macs enter
the endocytic pathway and are possibly degraded in lysosomes.
To measure exo-miRNA transfer from macrophages to ECs,
we cocultured an EC line, bEND.3, with iBMMs in transwell
Figure 4. Gene Transcript Levels Modulate miRNA Sorting to Exo-macs
(A) Mean-centered, hierarchical clustering of genes differentially expressed in UT (BMDM.1-4) and IL-4-treated (BMDM.1-4_IL-4) BMDMs.
(B) Correlation between the WIS-ratio [shown as ln(WIS-ratio)] and miRNA (indicated as miR) enrichment in exo-macs [versus BMDMs; shown as log2(FC) of
miRNA levels] after IL-4 treatment of BMDMs. The gray area identifies 95% of the events (95% prediction band).
(C) Bootstrap analysis of the data in (B) performed by randomly assigning log2(FC) to ln(WIS-ratio) values for 10
4 times (red curve, showing the distribution of R
values). The black, blue, and green curves show the distribution of R values obtained by removing 20%, 10%, and 5%, respectively, of the ln(WIS-ratio) and
log2(FC) values from the analysis in (B). The overlap between the random distribution and the resample distribution is indicated. The vertical lines identify
confidence interval (CI = 95%).
(D and E) Cumulative contribution of individual transcripts to the WIS (D, all detected miRNAs; E, selected miRNAs) in IL-4-treated versus UT BMDMs.
(F) Transcripts with FPKM values >80 as detected in BMDMs by RNA-seq. Selected transcripts are indicated.
(G) TaqMan analysis of the indicated genes (normalized to B2m) in IL-4–treated BMDMs. Data show mean values (±SEM, n = 3). Statistical analysis by unpaired
Student’s t test.
(H) TaqMan analysis of miR-16-5p and miR-218-5p (normalized to U6) in IL-4-treated BMDMs (left) and their exo-macs (right). Data show mean values (±SEM,
n = 3). Statistical analysis by unpaired Student’s t test.
(I) Cumulative distribution of the difference between FC values (D-FC; see Figure 1F and Table S2E) of individual miRNA pairs sharing the same seed sequence
(nucleotides in position 2–8; red line), all 3-mer/4-mer sequences outside the seed (blue/green lines), or randomly selected miRNA pairs (black line). Statistical
analysis by Kolmogorov-Smirnov test.assays. We then used low-density qPCR arrays to interrogate
themiRNA transcriptomes of ECs that were cultured either alone
or with iBMMs. Whereas the global miRNA transcriptome of ECs
was not significantly modulated by their coculture with iBMMsCell Re(data not shown), selected miRNAs were significantly increased
(Figure 5A). Of these, a sizable proportion was miRNAs that dis-
played a relatively high enrichment in the exo-macs compared to
ECs. Indeed, miRNAs that were >10-fold higher in exo-macsports 8, 1432–1446, September 11, 2014 ª2014 The Authors 1439
Figure 5. Global miRNA Transfer from
iBMMs to ECs upon Coculture
(A) Correlation between miRNA (indicated as miR)
levels in exo-macs from IL-4-treated iBMMs
[log2(FC) versus bENDs; x axis] and miRNA levels
in bENDs in coculture with IL-4–treated iBMMs
[log2(FC) versus bENDs; y axis]. Data show inde-
pendent experiments combined (n = 3 for exo-
macs; n = 2 for bENDs). miRNAs of interest are
indicated by red dots.
(B) Cumulative distribution of the FCs of miRNA
levels in bENDs in coculture with IL-4-treated
iBMMs versus bENDs. The black lines show FCs
of all miRs; the red lines show FCs of miRNAs
that are upregulated in exo-macs from IL-4-
treated iBMMs versus bENDs by >2-fold (top left)
or >10-fold (top right); the blue lines show FCs of
miRNAs that are upregulated in exo-macs from IL-
4-treated iBMMs versus bENDs by <2-fold (top
left) or <10-fold (top right). Bottom panels show
cumulative FCs using randomly selected miRNAs
(using the same number ofmiRNAs analyzed in the
top panels). Statistical analysis by two-sided Kol-
mogorov-Smirnov test.than ECs were globally and significantly increased in the ECs
upon coculture with iBMMs (Figure 5B). For example, miR-
142-3p and miR-223-3p, which are highly expressed in iBMMs
and their exo-macs but virtually undetectable in ECs, were signif-
icantly increased in ECs cocultured with iBMMs (Figure 5A).
Together, these data suggest the occurrence of miRNA transfer
from macrophages to ECs in vitro.
We then askedwhether exo-miRNAs can repress target genes
in ECs. To this aim, we constructed a panel of 32miRNA reporter
LVs, each incorporating two miRNA target (miRT) sequences
with perfect complementarity to a given miRNA into the 30 UTR
of a destabilized GFP (dGFP) transgene, which is expressed1440 Cell Reports 8, 1432–1446, September 11, 2014 ª2014 The Authorsfrom a ubiquitously active bidirectional
promoter that also controls the expres-
sion of the reporter gene, DLNGFR (Fig-
ure S6A). We also generated a control
LV expressing a dGFP sequence not
containing miRT sequences in its 30 UTR
(termed no-miRT). Following LV cell
transduction, the miRNA machinery will
degrade the dGFP transcript containing
miRT sequences only in the cells that
express the cognate miRNA, in a manner
that is dependent on miRNA abundance
and/or activity. On the other hand,
expression of DLNGFR is independent
of miRNA activity and is used as an inter-
nal normalizer to calculate GFP fold
repression as a direct readout of miRNA
activity, as described previously (Brown
et al., 2007; Mullokandov et al., 2012;
Squadrito et al., 2012).
We first measured endogenous miRNA
activity in IL-4-treated iBMMs and ECs(bEND.3). We found that several miRNAs were highly active in
both cell types, such as miR-21a-5p, miR-24-3p, Let-7e-5p,
and Let-7a-5p (Figure S6B). Other miRNAs showed specific
and/or high activity in either cell type, such as miR-142-3p,
miR-511-3p (specifically active in iBMMs), miR-92a-3p, and
miR-125a-5p (highly and specifically active in ECs). In order to
measure functional exo-miRNA transfer, iELCs expressing
miRNA reporter LVs were incubated with exo-macs from IL-4-
treated iBMMs. The exo-macs were readily uptaken by and
transferred miRNA activity to iELCs (+10%–20% miRNA activity
compared to cells not exposed to exo-macs; Figures S6C–S6E).
To rule out de novo endogenous miRNA activity, we transduced
Dicerfl/fl iELCs with a hPGK.Cre-Puro LV (Figure S2A) and
selected aDicer/ iELC clone for subsequent experiments (Fig-
ure S6F). As expected, endogenous miRNA activity was globally
disrupted in Dicer/ iELCs (Figure 6A), although Let-7 family
members displayed residual activity, possibly due to DICER-in-
dependent miRNA processing (Cifuentes et al., 2010). Of note,
we found substantially lower miRNA activity in Dicer/ than
Dicerfl/fl iELCs following their incubation with exo-macs (Fig-
ure S6G). This observation suggests that low-level exo-miRNA
activity may be masked by endogenous miRNA activity induced
by cell treatment with exosomes.
We then asked whether continuous exposure of ECs to mac-
rophages would increase transfer of exo-miRNA activity. Cocul-
turing iBMMs with Dicer/ iELCs led to substantial transfer
of miRNA activity from the macrophages to ECs (+10%–40%
miRNA activity compared to cells not cocultured with iBMMs;
Figure 6B). We then compared miRNA activity in different
ECs (bEND.3, Dicerfl/fl and Dicer/ iELCs) either treated with
exo-macs or cocultured with iBMMs. We consistently found
increased activity of selected miRNAs, including Let-7e-5p,
miR-142-3p, miR-188-5p, miR-146a-5p, and miR-150-5p, in
the ECs (Figures 6B–6E; Figures S6E and S6G). Of note, the
aforementioned miRNAs are either highly expressed in macro-
phages (e.g., miR-142-3p and miR-146a-5p) or enriched in the
exo-macs (e.g., miR-146a-5p, miR-188-5p, miR-150-5p, and
miR-467f; see Figure 1).
We then selected two exo-miRNAs, miR-188-5p and miR-
142-3p, for further validation experiments. Importantly, transfer
of miRNA activity to Dicer/ iELCs was greatly decreased
when exo-macs were isolated from miRNA-depleted, Dicer/
iBMMs (Figure 6F), demonstrating genuine transfer of exo-
miRNA activity from macrophages to ECs in vitro. Finally, in
order to study functional exo-miRNA transfer in vivo, we inocu-
lated Matrigel plugs containing Dicer/ iELCs transduced with
a miR-142-3p reporter LV (or a no-miRT LV), with or without
CD9.mCherry+ iBMMs, subcutaneously in athymic (nu/nu/)
mice. Eight days later, we analyzed theMatrigel plugs by flow cy-
tometry. Both the percentage and mCherry mean fluorescence
intensity (MFI) of the endogenous CD31+ ECs were significantly
higher in implants containing CD9.mCherry+ iBMMs (Figure 6G),
therefore showing exo-mac fusion with ECs in vivo. Moreover,
both the mCherry MFI and miR-142-3p activity were increased
in the Dicer/ iELCs from implants containing CD9.mCherry+
iBMMs (Figures 6H and 6I), indicating bona fide transfer of
exo-miRNA activity from macrophages to ECs in vivo.
DISCUSSION
The results of this study suggest that miRNA availability for
exosomal secretion is controlled, at least in part, by the cellular
levels of their targeted transcripts. By employing both transcrip-
tomic analyses and LV-reporter based assays, we found that
either physiological (cell-activation-dependent) or artificial over-
expression of miRNA target sequences promotes a relative
miRNA enrichment in P-bodies and depletion from MVBs and
exosomes. Conversely, artificial overexpression of a miRNA
enriches it in MVBs and exosomes. These results were corrobo-
rated by implementing a computational model to identifyCell RemiRNA:target interactions at the genome-wide level. IL-4-stimu-
lated macrophages were selected as a cellular system based on
our finding, as well as extensive previous work (Martinez et al.,
2009), that IL-4 activates macrophages by skewing the expres-
sion of a large proportion of genes. By comparing IL-4-treated
and UT macrophages, the model revealed a statistically signifi-
cant, negative correlation between miRNA:target interactions
in the cells and miRNA enrichment in exosomes. These findings
may imply that exosomal miRNA secretion is a mechanism
whereby cells rapidly dispose miRNAs in excess of their targets
to adjust miRNA:mRNA homeostasis.
miRNA:mRNA interactions were computed by considering
canonical seed:target matches predicted to occur among all
miRNAs and gene transcripts that were detected in our tran-
scriptomic data sets. Although short-sequence interactions
(6-mers) account for the vast majority of the predicted seed:tar-
get matches (70%), they contain many false positives and
have low specificity and precision (Ellwanger et al., 2011).
miRNA:target prediction algorithms like TargetScan therefore
favor seed:target matches with longer over shorter sequence
(Ellwanger et al., 2011; Grimson et al., 2007). To take these con-
siderations into account, the three main categories of seed:
target matches (i.e., 6-mer, 7-mer, and 8-mer) were assigned
a weighted score (0.3, 0.7, and 1.0, respectively) to minimize
the contribution of false positives (which are more prevalent
among 6-mers) and emphasize that of the most robust seed:
target matches (8-mers). For the sake of simplicity, our model
did not consider other miRNA/target features that may predict
miRNA activity, such as the conservation of the seed:target
match, the nucleotide composition of the seed:target flanking
regions, and free energy-based determinants, among others
(Wen et al., 2011). Moreover, we only considered seed:target
matches in the 30 UTR and excluded those in the 50 UTR and
ORF of the transcript. Several studies have indeed shown that
miRNA-binding sites in ORFs and 50 UTRs contribute minimally
to miRNA activity (Baek et al., 2008; Grimson et al., 2007); there-
fore, computing such interactions in our model would have
likely increased the proportion of false positives. For the same
reason, we did not consider noncanonical miRNA binding sites,
such as bulge seed:target interactions and those containing
G:U matches (Helwak et al., 2013). Because we implemented
simplified criteria aimed to minimize potential false positives, it
is possible that our results neglect the contribution of a fraction
of the miRNA:target interactions to exo-miRNA biogenesis and
hence underestimate the breadth of the phenomenon. In addi-
tion to the contribution of the aforementioned factors, the rela-
tive weakness of the anticorrelation suggests the very likely
scenario that additional mechanisms regulate miRNA sorting
to exosomes, such as miRNA family and sequence-specific or
biogenesis-dependent mechanisms (Kosaka et al., 2010; Villar-
roya-Beltri et al., 2013).
Several reports have shown that miRNA activity is higher in
cytoplasmic granules known as GW or P bodies, where proteins
that have a key role in translation repression, such asGW182 and
AGO2, have been shown to colocalize with untranslated mRNAs
(Jakymiw et al., 2005; Liu et al., 2005; Pillai, 2005). Of note, GW/P
bodies localize in close proximity toMVBs (Gibbings et al., 2009),
which are involved in exosome biogenesis. It is thereforeports 8, 1432–1446, September 11, 2014 ª2014 The Authors 1441
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tempting to speculate that miRNAs may passively traffic from
GW/P bodies to MVBs in response to oscillations of target
mRNA levels associated with such organelles. Recent studies
have also shown that miRNA activity may colocalize, at least in
part, with other subcellular compartments, such as the rough
ER (Stalder et al., 2013).
It has been proposed that the natural targets of a given miRNA
may act as ‘‘competing endogenous RNAs’’ (ceRNAs) that regu-
late miRNA bioavailability by competing with each other for
miRNA binding (Cesana et al., 2011; Poliseno et al., 2010; Tay
et al., 2011, 2014). For example, it was found that the PTEN
pseudogene, PTENP1, whose 30 UTR is highly homologous to
that of PTEN and contains manymiRNA target sites, upregulates
PTEN expression by competing with PTEN for the binding to
miRNAs (Poliseno et al., 2010). In another study, a human circu-
lar RNA antisense to CDR1 (termed CDR1as) operated as a
miRNA antagonist by sequestering miR-7 through 63 conserved
sites present in its sequence (Memczak et al., 2013). Our data
(Figures 2E and 2F) are in line with previous reports that exceed-
ingly high copies of a miRNA target are required in a cell to
disrupt miRNA activity through a ‘‘sponge effect’’ (Baccarini
et al., 2011; Brown and Naldini, 2009; Denzler et al., 2014; Gent-
ner et al., 2009). For example, we found that the genetic
knockout of Lyz2, which contributes to almost 3% of all the total
transcripts and at least 13% of the target sites for miR-218-5p in
BMDMs, did not affect the cellular levels of miR-218-5p but
significantly increased its loading into exosomes. Thus, changes
in endogenous target levels that are insufficient to detectably
alter miRNA abundance (and possibly activity) in the cell may
have the potential to modulate miRNA sorting to exosomes
through a ‘‘miRNA relocation effect’’ likely regulated by the
relative amounts of bound versus unbound miRNA and un-
known mechanisms of subcellular miRNA compartmentaliza-
tion (Ameres et al., 2010; Baccarini et al., 2011; Mullokandov
et al., 2012).
While our findings suggest that miRNA sorting to exosomes
may be a passive mechanism to dispose miRNAs in excess of
their cellular targets, increasing data indicate that exosomes
can be actively internalized by other cells, resulting in miRNA
transfer among cells of both homo- and heterotypic nature (Her-
genreider et al., 2012; Mittelbrunn et al., 2011; Ramachandran
and Palanisamy, 2012; Simons and Raposo, 2009; Skog et al.,
2008; Valadi et al., 2007). Furthermore, extracellular miRNAs
may represent biomarkers of disease and response to therapy.
For example, cancer cells display altered transcriptomic profiles,Figure 6. In Vivo Transfer of Exosomes and miRNA Activity from Macr
(A) Endogenous miRNA (indicated as miR) activity in Dicerfl/fl (n = 2) and Dicer/
normalized to iELCs transduced with a no-miRT control LV. Statistical analysis b
that display activity after Dicer deletion.
(B) miRNA activity in Dicer/ iELCs in coculture with iBMMs (versus Dicer/ iE
(C–E) miRNA activity in either iELCs or bENDs treated as indicated (versus UT), m
blue quadrant are recurrently increased in the ECs both by exo-mac treatment a
(F) miR-142-3p and miR-188-5p activity (normalized to a no-miRT LV) in Dicer
biological replicates and two independent experiments, of which one is shown). S
(G–I) Flow cytometry analysis of ECs fromMatrigel plugs either containing CD9.m
mCherry MFI of endogenous CD31+ ECs (right); percentage values were conve
mCherry MFI of DLNGFR+ Dicer/ iELCs; statistical analysis by unpaired Stud
Dicer/ iELCs in implants containing CD9.mCherry+ iBMMs (n = 5); statistical a
Cell Rewhich in turn may differentially modulate miRNA sorting to exo-
somes. Certain miRNA signatures identified in serum exosomes
indeed have both diagnostic and prognostic power for some
cancer types (Manterola et al., 2014; Pigati et al., 2010; Skog
et al., 2008).
Although miRNAs can traffic among cells via exosomes and
other microvesicles, the significance of exogenously derived
miRNAs for the global miRNA activity of a cell remains unclear.
To rigorously quantitate the effects of exosome-mediated
miRNA transfer in a model of macrophage-to-EC communica-
tion, we generated Dicer-deficient ECs and exposed them to
exosomes from either Dicer-proficient or Dicer-deficient macro-
phages. Although we detected bona fide transfer of miRNA ac-
tivity via exosomes, the contribution of exogenously derived
miRNAs to target gene repression was overall modest. While
our findings indicate that most of the exo-macs uptaken by
ECs end up in lysosomes, suggesting degradation of their
miRNA content, they do not exclude the possibility that certain
tissue microenvironments, such as tumors (Baer et al., 2013) or
atherosclerotic plaques (Hergenreider et al., 2012), may facilitate
miRNA transfer among cells by producing profuse amounts of
miRNA-enriched exosomes. Indeed, macrophages abundantly
enwrap immature blood vessels in tumors, a process that may
enhance exo-mac fusion with ECs and, consequently, miRNA
transfer to ECs engaged in angiogenesis (Baer et al., 2013;
Squadrito et al., 2013).
In summary, our data indicate that dynamic transcriptomic
changes that occur in response to cell activation may modulate
miRNA sorting to exosomes, at least in part, by differentially
engaging them at sites of miRNA activity (P bodies) and exo-
some biogenesis (MVBs). Such mechanism of miRNA compart-
mentalization regulated by miRNA targets may have implica-
tions for exosome-mediated miRNA transfer and intercellular
communication.
EXPERIMENTAL PROCEDURES
Additional or more detailed experimental procedures are available in the
Supplemental Experimental Procedures.
Lentiviral Vector Construction
Detailed information (sequences, primers, and cloning strategies) is available
in the Supplemental Experimental Procedures.
miRNA Reporter LVs
Thirty-two different miRNA reporter LVs were generated by introducing two
tandem sequences with perfect complementarity to specific miRNAs (miRTophages to ECs
iELCs (n = 4) measured by miRNA reporter LVs, shown as GFP fold-repression
y two-way ANOVA, with Sidak’s multiple comparison test. # indicates miRNAs
LCs; n = 2), measured by miRNA reporter LVs (normalized to a no-miRT LV).
easured by miRNA reporter LVs (normalized to a no-miRT LV). miRNAs in the
nd coculture with iBMMs.
/ iELCs treated with exo-macs from either Dicerfl/fl or Dicer/ iBMMs (three
tatistical analysis by two-way ANOVA, with Sidak’s multiple comparison test.
Cherry+ iBMMs (n = 7) or not (n = 13). (G) Percentage of mCherry+ ECs (left) and
rted to arcsin values and statistical analysis performed by unpaired t test. (H)
ent’s t test. (I) miR-142-3p activity (normalized to a no-miRT LV) in DLNGFR+
nalysis by unpaired Student’s t test.
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sequences) downstream to a destabilized GFP (dGFP) transgene expressed
from a bidirectional LV also encoding for a DLNGFR transgene (Amendola
et al., 2005).
LVs for Overexpression of miR-511-3p or Its Target Sequences
LVs to overexpress miR-511-3p, or its mutated form, were described previ-
ously (Squadrito et al., 2012). LVs to overexpress artificial or natural target
sequences for miR-511-3p are based on a SFFV.dGFP LV, which exploits
the strong SFFV promoter to overexpress a dGFP transgene linked to eight
tandem sequences with complementarity to a given miRNA (Gentner et al.,
2009). Natural target sequences for miR-511-3p were obtained from the
Rock2 30 UTR, as described previously (Squadrito et al., 2012).
LV to Express Cre Recombinase or Immortalize BMDMs
The Cre LV was generated by replacing the DLNGFR and the GFP DNA se-
quences of a bidirectional LV (Amendola et al., 2005) with Cre and puromycin
resistance (Puro) coding sequences, respectively. The SV40 large T antigen
(TAg) coding sequence (a gift from Didier Trono, EPFL) was cloned in an
SFFV promoter-containing LV (Squadrito et al., 2012).
Exosome Isolation
In order to isolate exo-macs, BMDMs and iBMMs were cultured in serum-free
medium (SFM medium; Life Technologies). In coculture experiments (e.g.,
iBMMs with ECs), culture medium was supplemented with FBS previously
depleted of exosomes by ultracentrifugation at 134,000 3 g for 6 hr. In order
to isolate exo-macs, we employed two different techniques: (1) ExoQuick TC
(System Biosciences), for primary BMDMs; and (2) ultracentrifugation, for
iBMMs. Exo-macs were used immediately or stored at80C. Detailed proto-
cols are available in Supplemental Experimental Procedures.
Low-Density miRNA TaqMan Arrays
The Rodent MicroRNA TaqMan Array (Life Technologies) was used to profile
miRNAs in BMDMs; IL-4-treated BMDMs; bEND.3; bEND.3 cocultured with
macrophages; exo-macs from UT BMDMs; and exo-macs from IL-4-treated
BMDMs. The data were collected and processed using the SDS2.4 software
(Life Technologies). miRNAs that had fewer than two out of three determina-
tions per conditionwere excluded from the analysis. Ct valueswere normalized
using the quantile method. Additional information is available in the Supple-
mental Experimental Procedures.
RNA-Seq of BMDMs
UT (n = 4) and IL-4-treated (n = 4) BMDMs were lysed in Qiazol and total RNA
extracted. Total RNA was then depleted of rRNA using the Ribo-Zero RNA
removal kit (Epicenter Biotechnologies). Illumina sequencing libraries were
prepared according to the TruSeq RNA v2 Sample Preparation Guide (Revi-
sion B) and sequencing performed on a HiSeq 2500 (Illumina) using paired-
end cBot v3 clustering and TruSeq SBS reagents. Libraries were sequenced
using 2 3 100 bp paired-end reads. The 100 nt paired-end reads were then
mapped to mm9 reference genome using Tophat software version 2.0.9,
with default options, using mm9 UCSC reference genes GTF. Count data for
each exon were generated using htseq-count from the HTseq package
(http://www-huber.embl.de/users/anders/HTSeq/; version 0.5.4p3). Frag-
ments per kilobase per million of reads (FPKM) were estimated for transcripts
in each of the conditions using the cufflinks software (version 2.1.1). Additional
information is available in the Supplemental Experimental Procedures.
Gene/miRNA Expression Analysis by TaqMan Arrays and RNA-Seq
Differentially expressed mature miRNAs (TaqMan arrays) and gene transcripts
(RNA-seq) were identified using the limma package in R. For gene transcripts,
the raw read counts per genewere first filtered forminimal expression (average
of raw counts was more than five across samples), normalized to the relative
size of each library using the R package edgeR, and then transformed to
log2-cpm (counts per million reads) using the voom function. Empirical Bayes
moderated t statistics and corresponding p values were then computed for
the comparison (IL-4-treated versus UT BMDMs/exo-macs). p values were
adjusted for multiple comparisons using the Benjamini Hochberg procedure.
Gene transcripts and miRNAs with an adjusted p% 0.05 were considered to
be differentially expressed. Additional information is available in Supplemental
Experimental Procedures.1444 Cell Reports 8, 1432–1446, September 11, 2014 ª2014 The AuStatistical Analysis
Statistical analysis of the data is described in the figure legends. Error bars
show mean values ± SEM, unless stated otherwise. Statistical significance
of the data is indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
ACCESSION NUMBERS
RNA-seq data (eight BMDM samples) have been deposited to the NCBI Gene
Expression Omnibus under accession number GSE58283.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedure, six
figures, and three tables and can be found with this article online at http://dx.
doi.org/10.1016/j.celrep.2014.07.035.
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